Stegmann Thomas 4
4 · CardioVascular BioTherapeutics, Inc. · Filed Aug 18, 2009
Insider Transaction Report
Form 4
Stegmann Thomas
10% Owner
Transactions
- Sale
Common Stock
2009-08-11$0.27/sh−218,693$59,047→ 15,401,915 total - Sale
Common Stock
2009-08-10$0.26/sh−200,000$52,000→ 16,020,608 total - Sale
Common Stock
2009-08-10$0.28/sh−200,000$56,000→ 15,620,608 total - Sale
Common Stock
2009-08-10$0.24/sh−200,000$48,000→ 16,420,608 total - Sale
Common Stock
2009-08-10$0.27/sh−200,000$54,000→ 15,820,608 total - Sale
Common Stock
2009-08-11$0.28/sh−200,000$55,000→ 15,201,915 total - Sale
Common Stock
2009-08-10$0.24/sh−100,000$23,900→ 16,620,608 total - Sale
Common Stock
2009-08-10$0.25/sh−200,000$50,000→ 16,220,608 total